Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 11
Submit an article Journal homepage
938
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma

May HagiwaraPolicy Analysis Inc. (PAI) Brookline, MAUSACorrespondence[email protected]
,
Michelle D. HackshawGlaxoSmithKline Collegeville, PAUSA
&
Gerry OsterPolicy Analysis Inc. (PAI) Brookline, MAUSA
Pages 1300-1306 | Accepted 21 Aug 2013, Published online: 19 Sep 2013

References

  • Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917
  • American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society, 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed November, 2012
  • SEER Program Public Use Tapes 1973--2002, November 2004 Submission. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Science, Surveillance Research Program, Cancer Statistics Branch, 2005
  • American Cancer Society. Kidney Cancer (Adult) -- Renal Cell Carcinoma. Atlanta, GA: American Cancer Society, 2013. http://www.cancer.org/acs/groups/cid/documents/webcontent/003052-pdf.pdf. Accessed July, 2013
  • Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008;34:193–205
  • Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865–75
  • Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000;163:408–17
  • Chowdhury S, Larkin JM, Gore ME. Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies. Eur J Cancer 2008;44:2152–61
  • Highlights of prescribing information: Avastin (bevacizumab), Solution for intravenous infusion. Genentech, Inc., 2011. http://www.gene.com/gene/products/information/pdf/avastin-prescribing.pdf. Accessed April, 2011
  • Highlights of prescribing information: Nexavar (sorafenib) tablets, oral. Bayer HealthCare Pharmaceuticals Inc., 2011. http://www.univgraph.com/bayer/inserts/nexavar.pdf. Accessed April, 2011
  • Highlights of prescribing information: Sutent (sunitinib malate) capsules, oral. Pfizer Inc., 2010. http://labeling.pfizer.com/ShowLabeling.aspx?id=607. Accessed April, 2011
  • Highlights of prescribing information: Votrient (pazopanib) tablets. GlaxoSmithKline, 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022465lbl.pdf. Accessed April, 2011
  • National Cancer Institute. SEER Surveillance, Epidemiology, and End Results Program. NIH Publication No. 05-4772. September 2005. http://seer.cancer.gov/about/. Accessed October, 2011
  • Choueiri TK, McDermott D, Sheng Duh M, et al. Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: results from a medical chart review study. J Urol Oncol 2012;30:848–55
  • Feinberg BA, Jolly P, Wang ST, et al. Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics. Med Oncol 2012;29:786–94
  • Mickisch G, Gore M, Escudier B, et al. Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: Bevacizumab in combination with interferon-α2a compared with sunitinib. Br J Cancer 2010;102:80–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.